Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 73 entries
Sorted by: Best Match Show Resources per page
Barley β-glucan in poultry diets.

Annals of translational medicine

Jacob JP, Pescatore AJ.
PMID: 25332996
Ann Transl Med. 2014 Feb;2(2):20. doi: 10.3978/j.issn.2305-5839.2014.01.02.

There has been an increased interest in the use of immunomodulators as substitutes for antibiotics in food animal production. Beta-glucans from yeast and fungi may be ideal substitutes because of their positive effects on the avian immune system without...

Cite
Jacob JP, Pescatore AJ. Barley β-glucan in poultry diets. Ann Transl Med. 2014;2(2):20doi: 10.3978/j.issn.2305-5839.2014.01.02.
Jacob, J. P., & Pescatore, A. J. (2014). Barley β-glucan in poultry diets. Annals of translational medicine, 2(2), 20. https://doi.org/10.3978/j.issn.2305-5839.2014.01.02
Jacob, Jacqueline P, and Pescatore, Anthony J. "Barley β-glucan in poultry diets." Annals of translational medicine vol. 2,2 (2014): 20. doi: https://doi.org/10.3978/j.issn.2305-5839.2014.01.02
Jacob JP, Pescatore AJ. Barley β-glucan in poultry diets. Ann Transl Med. 2014 Feb;2(2):20. doi: 10.3978/j.issn.2305-5839.2014.01.02. PMID: 25332996; PMCID: PMC4202475.
Copy Download .nbib Format: NLM
Physiological functions of plant cell coverings.

Journal of plant research

Hoson T.
PMID: 12582731
J Plant Res. 2002 Aug;115(4):277-82. doi: 10.1007/s10265-002-0035-9. Epub 2002 Jun 18.

The cell coverings of plants have two important functions in plant life. Plant cell coverings are deeply involved in the regulation of the life cycle of plants: each stage of the life cycle, such as germination, vegetative growth, reproductive...

Cite
Hoson T. Physiological functions of plant cell coverings. J Plant Res. 2002;115(4):277-82doi: 10.1007/s10265-002-0035-9.
Hoson, T. (2002). Physiological functions of plant cell coverings. Journal of plant research, 115(4), 277-82. https://doi.org/10.1007/s10265-002-0035-9
Hoson, Takayuki. "Physiological functions of plant cell coverings." Journal of plant research vol. 115,4 (2002): 277-82. doi: https://doi.org/10.1007/s10265-002-0035-9
Hoson T. Physiological functions of plant cell coverings. J Plant Res. 2002 Aug;115(4):277-82. doi: 10.1007/s10265-002-0035-9. Epub 2002 Jun 18. PMID: 12582731.
Copy Download .nbib Format: NLM
The effects of diets enriched in beta-glucans on blood lipoprotein concentrations.

Journal of clinical lipidology

Chen J, Huang XF.
PMID: 21291810
J Clin Lipidol. 2009 May-Jun;3(3):154-8. doi: 10.1016/j.jacl.2009.04.054. Epub 2009 May 05.

Dietary beta-glucans lower the blood concentrations of cholesterol in animals and humans. Recent studies have uncovered mechanisms by which dietary beta-glucans may regulate cholesterol homeostasis. There is evidence that beta-glucans sequester bile acids in the intestine, reducing their reabsorption...

Cite
Chen J, Huang XF. The effects of diets enriched in beta-glucans on blood lipoprotein concentrations. J Clin Lipidol. 2009;3(3):154-8doi: 10.1016/j.jacl.2009.04.054.
Chen, J., & Huang, X. F. (2009). The effects of diets enriched in beta-glucans on blood lipoprotein concentrations. Journal of clinical lipidology, 3(3), 154-8. https://doi.org/10.1016/j.jacl.2009.04.054
Chen, Jiezhong, and Huang, Xu-Feng. "The effects of diets enriched in beta-glucans on blood lipoprotein concentrations." Journal of clinical lipidology vol. 3,3 (2009): 154-8. doi: https://doi.org/10.1016/j.jacl.2009.04.054
Chen J, Huang XF. The effects of diets enriched in beta-glucans on blood lipoprotein concentrations. J Clin Lipidol. 2009 May-Jun;3(3):154-8. doi: 10.1016/j.jacl.2009.04.054. Epub 2009 May 05. PMID: 21291810.
Copy Download .nbib Format: NLM
Radioimmunotherapy of Blastomycosis in a Mouse Model With a (1→3)-β-Glucans Targeting Antibody.

Frontiers in microbiology

Helal M, Allen KJH, van Dijk B, Nosanchuk JD, Snead E, Dadachova E.
PMID: 32117166
Front Microbiol. 2020 Feb 07;11:147. doi: 10.3389/fmicb.2020.00147. eCollection 2020.

Invasive fungal infections (IFI) cause devastating morbidity and mortality, with the number of IFIs more than tripling since 1979. Our laboratories were the first to demonstrate that radiolabeled microorganism-specific monoclonal antibodies are highly effective for treatment of experimental fungal,...

Cite
Helal M, Allen KJH, van Dijk B, et al. Radioimmunotherapy of Blastomycosis in a Mouse Model With a (1→3)-β-Glucans Targeting Antibody. Front Microbiol. 2020;11:147doi: 10.3389/fmicb.2020.00147.
Helal, M., Allen, K. J. H., van Dijk, B., Nosanchuk, J. D., Snead, E., & Dadachova, E. (2020). Radioimmunotherapy of Blastomycosis in a Mouse Model With a (1→3)-β-Glucans Targeting Antibody. Frontiers in microbiology, 11147. https://doi.org/10.3389/fmicb.2020.00147
Helal, Muath, et al. "Radioimmunotherapy of Blastomycosis in a Mouse Model With a (1→3)-β-Glucans Targeting Antibody." Frontiers in microbiology vol. 11 (2020): 147. doi: https://doi.org/10.3389/fmicb.2020.00147
Helal M, Allen KJH, van Dijk B, Nosanchuk JD, Snead E, Dadachova E. Radioimmunotherapy of Blastomycosis in a Mouse Model With a (1→3)-β-Glucans Targeting Antibody. Front Microbiol. 2020 Feb 07;11:147. doi: 10.3389/fmicb.2020.00147. eCollection 2020. PMID: 32117166; PMCID: PMC7019017.
Copy Download .nbib Format: NLM
Beta-Glucans from Fungi: Biological and Health-Promoting Potential in the COVID-19 Pandemic Era.

Nutrients

Mirończuk-Chodakowska I, Kujawowicz K, Witkowska AM.
PMID: 34836215
Nutrients. 2021 Nov 06;13(11). doi: 10.3390/nu13113960.

Beta-glucans comprise a group of polysaccharides of natural origin found in bacteria, algae, and plants, e.g., cereal seeds, as well as microfungi and macrofungi (mushrooms), which are characterized by diverse structures and functions. They are known for their metabolic...

Cite
Mirończuk-Chodakowska I, Kujawowicz K, Witkowska AM. Beta-Glucans from Fungi: Biological and Health-Promoting Potential in the COVID-19 Pandemic Era. Nutrients. 2021;13(11)doi: 10.3390/nu13113960.
Mirończuk-Chodakowska, I., Kujawowicz, K., & Witkowska, A. M. (2021). Beta-Glucans from Fungi: Biological and Health-Promoting Potential in the COVID-19 Pandemic Era. Nutrients, 13(11), . https://doi.org/10.3390/nu13113960
Mirończuk-Chodakowska, Iwona, et al. "Beta-Glucans from Fungi: Biological and Health-Promoting Potential in the COVID-19 Pandemic Era." Nutrients vol. 13,11 (2021). doi: https://doi.org/10.3390/nu13113960
Mirończuk-Chodakowska I, Kujawowicz K, Witkowska AM. Beta-Glucans from Fungi: Biological and Health-Promoting Potential in the COVID-19 Pandemic Era. Nutrients. 2021 Nov 06;13(11). doi: 10.3390/nu13113960. PMID: 34836215; PMCID: PMC8623785.
Copy Download .nbib Format: NLM
Metabolic variables of obese dogs with insulin resistance supplemented with yeast beta-glucan.

BMC veterinary research

Ferreira CS, Vendramini THA, Amaral AR, Rentas MF, Ernandes MC, da Silva FL, Oba PM, de Oliveira Roberti Filho F, Brunetto MA.
PMID: 34980115
BMC Vet Res. 2022 Jan 03;18(1):14. doi: 10.1186/s12917-021-03106-2.

BACKGROUND: Obesity is one of the most common nutritional disorders in dogs and cats and is related to the development metabolic comorbidities. Weight loss is the recommended treatment, but success is difficult due to the poor satiety control. Yeast...

Cite
Ferreira CS, Vendramini THA, Amaral AR, et al. Metabolic variables of obese dogs with insulin resistance supplemented with yeast beta-glucan. BMC Vet Res. 2022;18(1):14doi: 10.1186/s12917-021-03106-2.
Ferreira, C. S., Vendramini, T. H. A., Amaral, A. R., Rentas, M. F., Ernandes, M. C., da Silva, F. L., Oba, P. M., de Oliveira Roberti Filho, F., & Brunetto, M. A. (2022). Metabolic variables of obese dogs with insulin resistance supplemented with yeast beta-glucan. BMC veterinary research, 18(1), 14. https://doi.org/10.1186/s12917-021-03106-2
Ferreira, Chayanne Silva, et al. "Metabolic variables of obese dogs with insulin resistance supplemented with yeast beta-glucan." BMC veterinary research vol. 18,1 (2022): 14. doi: https://doi.org/10.1186/s12917-021-03106-2
Ferreira CS, Vendramini THA, Amaral AR, Rentas MF, Ernandes MC, da Silva FL, Oba PM, de Oliveira Roberti Filho F, Brunetto MA. Metabolic variables of obese dogs with insulin resistance supplemented with yeast beta-glucan. BMC Vet Res. 2022 Jan 03;18(1):14. doi: 10.1186/s12917-021-03106-2. PMID: 34980115; PMCID: PMC8722019.
Copy Download .nbib Format: NLM
Phase I Trial of Oral Yeast-Derived β-Glucan to Enhance Anti-GD2 Immunotherapy of Resistant High-Risk Neuroblastoma.

Cancers

Cardenas FI, Mauguen A, Cheung IY, Kramer K, Kushner BH, Ragupathi G, Cheung NV, Modak S.
PMID: 34944886
Cancers (Basel). 2021 Dec 14;13(24). doi: 10.3390/cancers13246265.

Beta glucans, complex polysaccharides, prime leukocyte dectin-1 and CR3-receptors and enhance anti-tumor cytotoxicity of complement-activating monoclonal antibodies. We conducted a phase I study (clinicaltrials.gov NCT00492167) to determine the safety of the combination of yeast-derived beta glucan (BG) and anti-GD2...

Cite
Cardenas FI, Mauguen A, Cheung IY, et al. Phase I Trial of Oral Yeast-Derived β-Glucan to Enhance Anti-GD2 Immunotherapy of Resistant High-Risk Neuroblastoma. Cancers (Basel). 2021;13(24)doi: 10.3390/cancers13246265.
Cardenas, F. I., Mauguen, A., Cheung, I. Y., Kramer, K., Kushner, B. H., Ragupathi, G., Cheung, N. V., & Modak, S. (2021). Phase I Trial of Oral Yeast-Derived β-Glucan to Enhance Anti-GD2 Immunotherapy of Resistant High-Risk Neuroblastoma. Cancers, 13(24), . https://doi.org/10.3390/cancers13246265
Cardenas, Fiorella Iglesias, et al. "Phase I Trial of Oral Yeast-Derived β-Glucan to Enhance Anti-GD2 Immunotherapy of Resistant High-Risk Neuroblastoma." Cancers vol. 13,24 (2021). doi: https://doi.org/10.3390/cancers13246265
Cardenas FI, Mauguen A, Cheung IY, Kramer K, Kushner BH, Ragupathi G, Cheung NV, Modak S. Phase I Trial of Oral Yeast-Derived β-Glucan to Enhance Anti-GD2 Immunotherapy of Resistant High-Risk Neuroblastoma. Cancers (Basel). 2021 Dec 14;13(24). doi: 10.3390/cancers13246265. PMID: 34944886; PMCID: PMC8699451.
Copy Download .nbib Format: NLM
Pleurotus eryngii improves postprandial glycaemia, hunger and fullness perception, and enhances ghrelin suppression in people with metabolically unhealthy obesity.

Pharmacological research

Kleftaki SA, Simati S, Amerikanou C, Gioxari A, Tzavara C, Zervakis GI, Kalogeropoulos N, Kokkinos A, Kaliora AC.
PMID: 34798266
Pharmacol Res. 2021 Nov 16;175:105979. doi: 10.1016/j.phrs.2021.105979. Epub 2021 Nov 16.

The aim of this study was to examine potential postprandial benefits of Pleurotus eryngii in nineteen volunteers with metabolically unhealthy obesity. An acute, randomized, crossover-designed trial comparing a meal with Pleurotus eryngii and a control meal was performed. The...

Cite
Kleftaki SA, Simati S, Amerikanou C, et al. Pleurotus eryngii improves postprandial glycaemia, hunger and fullness perception, and enhances ghrelin suppression in people with metabolically unhealthy obesity. Pharmacol Res. 2021;175:105979doi: 10.1016/j.phrs.2021.105979.
Kleftaki, S. A., Simati, S., Amerikanou, C., Gioxari, A., Tzavara, C., Zervakis, G. I., Kalogeropoulos, N., Kokkinos, A., & Kaliora, A. C. (2021). Pleurotus eryngii improves postprandial glycaemia, hunger and fullness perception, and enhances ghrelin suppression in people with metabolically unhealthy obesity. Pharmacological research, 175105979. https://doi.org/10.1016/j.phrs.2021.105979
Kleftaki, Stamatia-Angeliki, et al. "Pleurotus eryngii improves postprandial glycaemia, hunger and fullness perception, and enhances ghrelin suppression in people with metabolically unhealthy obesity." Pharmacological research vol. 175 (2021): 105979. doi: https://doi.org/10.1016/j.phrs.2021.105979
Kleftaki SA, Simati S, Amerikanou C, Gioxari A, Tzavara C, Zervakis GI, Kalogeropoulos N, Kokkinos A, Kaliora AC. Pleurotus eryngii improves postprandial glycaemia, hunger and fullness perception, and enhances ghrelin suppression in people with metabolically unhealthy obesity. Pharmacol Res. 2021 Nov 16;175:105979. doi: 10.1016/j.phrs.2021.105979. Epub 2021 Nov 16. PMID: 34798266.
Copy Download .nbib Format: NLM
Effectiveness of Oat-Hull-Based Ingredient as Fat Replacer to Produce Low Fat Burger with High Beta-Glucans Content.

Foods (Basel, Switzerland)

Summo C, De Angelis D, Difonzo G, Caponio F, Pasqualone A.
PMID: 32759875
Foods. 2020 Aug 04;9(8). doi: 10.3390/foods9081057.

Low-fat beef burgers with high beta-glucan content was obtained using a gel made from an oat-hull-based ingredient as fat replacer. Two levels of fat substitution were considered: 50% (T1) and 100% (T2). The nutritional composition, cooking yield, textural properties,...

Cite
Summo C, De Angelis D, Difonzo G, et al. Effectiveness of Oat-Hull-Based Ingredient as Fat Replacer to Produce Low Fat Burger with High Beta-Glucans Content. Foods. 2020;9(8)doi: 10.3390/foods9081057.
Summo, C., De Angelis, D., Difonzo, G., Caponio, F., & Pasqualone, A. (2020). Effectiveness of Oat-Hull-Based Ingredient as Fat Replacer to Produce Low Fat Burger with High Beta-Glucans Content. Foods (Basel, Switzerland), 9(8), . https://doi.org/10.3390/foods9081057
Summo, Carmine, et al. "Effectiveness of Oat-Hull-Based Ingredient as Fat Replacer to Produce Low Fat Burger with High Beta-Glucans Content." Foods (Basel, Switzerland) vol. 9,8 (2020). doi: https://doi.org/10.3390/foods9081057
Summo C, De Angelis D, Difonzo G, Caponio F, Pasqualone A. Effectiveness of Oat-Hull-Based Ingredient as Fat Replacer to Produce Low Fat Burger with High Beta-Glucans Content. Foods. 2020 Aug 04;9(8). doi: 10.3390/foods9081057. PMID: 32759875; PMCID: PMC7466358.
Copy Download .nbib Format: NLM
Therapeutic effects of different doses of prebiotic (isolated from S.

Diabetology & metabolic syndrome

de Sales Guilarducci J, Marcelino BAR, Konig IFM, Orlando TM, Varaschin MS, Pereira LJ.
PMID: 32793305
Diabetol Metab Syndr. 2020 Aug 10;12:69. doi: 10.1186/s13098-020-00576-6. eCollection 2020.

BACKGROUND: The regular intake of fiber generates numerous health benefits. However, the efficacy depends on the duration of consumption and the ingested dose. Studies investigating the optimal dose are of interest to enable the inclusion of fiber in the...

Cite
de Sales Guilarducci J, Marcelino BAR, Konig IFM, et al. Therapeutic effects of different doses of prebiotic (isolated from S. Diabetol Metab Syndr. 2020;12:69doi: 10.1186/s13098-020-00576-6.
de Sales Guilarducci, J., Marcelino, B. A. R., Konig, I. F. M., Orlando, T. M., Varaschin, M. S., & Pereira, L. J. (2020). Therapeutic effects of different doses of prebiotic (isolated from S. Diabetology & metabolic syndrome, 1269. https://doi.org/10.1186/s13098-020-00576-6
de Sales Guilarducci, Janina, et al. "Therapeutic effects of different doses of prebiotic (isolated from S." Diabetology & metabolic syndrome vol. 12 (2020): 69. doi: https://doi.org/10.1186/s13098-020-00576-6
de Sales Guilarducci J, Marcelino BAR, Konig IFM, Orlando TM, Varaschin MS, Pereira LJ. Therapeutic effects of different doses of prebiotic (isolated from S. Diabetol Metab Syndr. 2020 Aug 10;12:69. doi: 10.1186/s13098-020-00576-6. eCollection 2020. PMID: 32793305; PMCID: PMC7418400.
Copy Download .nbib Format: NLM
Pleurotus eryngii improves postprandial glycaemia, hunger and fullness perception, and enhances ghrelin suppression in people with metabolically unhealthy obesity.

Pharmacological research

Kleftaki SA, Simati S, Amerikanou C, Gioxari A, Tzavara C, Zervakis GI, Kalogeropoulos N, Kokkinos A, Kaliora AC.
PMID: 34798266
Pharmacol Res. 2021 Nov 16;175:105979. doi: 10.1016/j.phrs.2021.105979. Epub 2021 Nov 16.

The aim of this study was to examine potential postprandial benefits of Pleurotus eryngii in nineteen volunteers with metabolically unhealthy obesity. An acute, randomized, crossover-designed trial comparing a meal with Pleurotus eryngii and a control meal was performed. The...

Cite
Kleftaki SA, Simati S, Amerikanou C, et al. Pleurotus eryngii improves postprandial glycaemia, hunger and fullness perception, and enhances ghrelin suppression in people with metabolically unhealthy obesity. Pharmacol Res. 2021;175:105979doi: 10.1016/j.phrs.2021.105979.
Kleftaki, S. A., Simati, S., Amerikanou, C., Gioxari, A., Tzavara, C., Zervakis, G. I., Kalogeropoulos, N., Kokkinos, A., & Kaliora, A. C. (2021). Pleurotus eryngii improves postprandial glycaemia, hunger and fullness perception, and enhances ghrelin suppression in people with metabolically unhealthy obesity. Pharmacological research, 175105979. https://doi.org/10.1016/j.phrs.2021.105979
Kleftaki, Stamatia-Angeliki, et al. "Pleurotus eryngii improves postprandial glycaemia, hunger and fullness perception, and enhances ghrelin suppression in people with metabolically unhealthy obesity." Pharmacological research vol. 175 (2021): 105979. doi: https://doi.org/10.1016/j.phrs.2021.105979
Kleftaki SA, Simati S, Amerikanou C, Gioxari A, Tzavara C, Zervakis GI, Kalogeropoulos N, Kokkinos A, Kaliora AC. Pleurotus eryngii improves postprandial glycaemia, hunger and fullness perception, and enhances ghrelin suppression in people with metabolically unhealthy obesity. Pharmacol Res. 2021 Nov 16;175:105979. doi: 10.1016/j.phrs.2021.105979. Epub 2021 Nov 16. PMID: 34798266.
Copy Download .nbib Format: NLM
Evaluation of novel nutraceuticals based on the combination of oat beta-glucans and a green coffee phenolic extract to combat obesity and its comorbidities. A randomized, dose-response, parallel trial.

Food & function

Mateos R, García-Cordero J, Bravo-Clemente L, Sarriá B.
PMID: 34919104
Food Funct. 2021 Dec 17; doi: 10.1039/d1fo02272e. Epub 2021 Dec 17.

Obesity and its associated comorbidities are a major public health concern worldwide. Reduced energy intake and increased physical activity interventions have limited success in the long term. Nutraceuticals might be an alternative means to help lose weight and reduce...

Cite
Mateos R, García-Cordero J, Bravo-Clemente L, et al. Evaluation of novel nutraceuticals based on the combination of oat beta-glucans and a green coffee phenolic extract to combat obesity and its comorbidities. A randomized, dose-response, parallel trial. Food Funct. 2021;doi: 10.1039/d1fo02272e.
Mateos, R., García-Cordero, J., Bravo-Clemente, L., & Sarriá, B. (2021). Evaluation of novel nutraceuticals based on the combination of oat beta-glucans and a green coffee phenolic extract to combat obesity and its comorbidities. A randomized, dose-response, parallel trial. Food & function, . https://doi.org/10.1039/d1fo02272e
Mateos, Raquel, et al. "Evaluation of novel nutraceuticals based on the combination of oat beta-glucans and a green coffee phenolic extract to combat obesity and its comorbidities. A randomized, dose-response, parallel trial." Food & function vol. (2021). doi: https://doi.org/10.1039/d1fo02272e
Mateos R, García-Cordero J, Bravo-Clemente L, Sarriá B. Evaluation of novel nutraceuticals based on the combination of oat beta-glucans and a green coffee phenolic extract to combat obesity and its comorbidities. A randomized, dose-response, parallel trial. Food Funct. 2021 Dec 17; doi: 10.1039/d1fo02272e. Epub 2021 Dec 17. PMID: 34919104.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 73 entries